Get App
Last Updated : Jun 10, 2019 03:36 PM IST | Source:

Buy Divi’s Laboratories; target of Rs 1850: Sharekhan

Sharekhan is bullish on Divi’s Laboratories has recommended buy rating on the stock with a target price of Rs 1850 in its research report dated May 28, 2019.

Broker Research @moneycontrolcom
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Divi’s Laboratories

Sales set for healthy growth in the next two years; aggressive capex plan to monetise opportunities in the US and China. Benefits of capex plan to accrue from FY2021; No pending regulatory hurdles. We expect company to report sales and profit CAGRs of 21% and 22%, respectively during FY2019-FY2021E; Q4 earnings lagged estimates due to one-offs.


We maintain our Buy recommendation with a PT of Rs. 1,850.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Subscribe to Moneycontrol Pro and gain access to curated markets data, exclusive trading recommendations, independent equity analysis, actionable investment ideas, nuanced takes on macro, corporate and policy actions, practical insights from market gurus and much more.
First Published on Jun 10, 2019 03:36 pm
Follow us on
Available On
PCI DSS Compliant